Intuitive Surgical, Inc. (BKK:ISRG19)

Market Cap	5.48T -20.9%
Revenue (ttm)	317.41B +20.5%
Net Income	90.07B +23.0%
EPS	248.20 +22.6%
Shares Out	n/a
PE Ratio	60.84
Forward PE	48.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,902
Average Volume	13,485
Open	3.840
Previous Close	3.860
Day's Range	3.840 - 3.900
52-Week Range	3.740 - 4.280
Beta	n/a
RSI	34.99
Earnings Date	Jan 21, 2026

About Intuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1995
• Employees: 17,021
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: ISRG19

Financial Performance

In 2025, Intuitive Surgical's revenue was $10.06 billion, an increase of 20.51% compared to the previous year's $8.35 billion. Earnings were $2.86 billion, an increase of 22.97%.

Financial numbers in USD